Nootropic and neurotrophic peptides studied for cognition and recovery.
Neuroactive peptides are studied for their influence on neurotrophic signaling, synaptic plasticity, and resilience to ischemic and oxidative stress. Research areas range from cognitive performance and memory consolidation to recovery after ischemic stroke and models of neurodegeneration.
Proposed mechanisms include modulation of BDNF and other neurotrophins, regulation of monoaminergic and GABAergic tone, and protection of neuronal mitochondria. The blood–brain-barrier permeability of a given sequence is a central variable, and much of the clinical literature originates outside large Western registries.
GHRH analog FDA-approved for HIV-associated lipodystrophy.
View profileRussian synthetic ACTH(4-10) analog studied for nootropic and neuroprotective effects.
View profileSynthetic heptapeptide analog of tuftsin investigated as an anxiolytic.
View profileEssential redox cofactor central to mitochondrial bioenergetics and sirtuin activity.
View profile